ロード中...

Advances in targeted therapy for acute myeloid leukemia

Acute myeloid leukemia (AML) is a clonal malignancy characterized by genetic heterogeneity due to recurrent gene mutations. Treatment with cytotoxic chemotherapy has been the standard of care for more than half of a century. Although much progress has been made toward improving treatment related mor...

詳細記述

保存先:
書誌詳細
出版年:Biomark Res
主要な著者: Yu, Jifeng, Jiang, Peter Y. Z., Sun, Hao, Zhang, Xia, Jiang, Zhongxing, Li, Yingmei, Song, Yongping
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7238648/
https://ncbi.nlm.nih.gov/pubmed/32477567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-020-00196-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!